Skip to content

William D. Zigrang, M.D.

NPI 1821002783ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Burlingame, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Burlingame, California, licensed in CA, with an NPI issued in July 2006. Part D covered 146 prescriptions written in 2024, 54% of them generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2024, $183.27 in all, mostly food and beverage.

Overview

NPI1821002783
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJul 28, 2006
Last updated in NPPESOct 16, 2017

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)

Part D prescriptions in 2024

Prescriptions (claims)146 · 339 30-day fills
Patients37
Total drug cost$54,026
Generic share54% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$183.27 · 2 payments from 2 companies

Top paying companies in 2024

CompanyAmountPayments
Abbott Laboratories$123.921
Corcept Therapeutics$59.351

What the 2024 payments were for

  • Food and Beverage$183.27 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Burlingame

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →